Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients
Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients
About this item
Full title
Author / Creator
Marofi, Faroogh , Rahman, Heshu Sulaiman , Al-Obaidi, Zaid Mahdi Jaber , Jalil, Abduladheem Turki , Abdelbasset, Walid Kamal , Suksatan, Wanich , Dorofeev, Aleksei Evgenievich , Shomali, Navid , Chartrand, Max Stanley , Pathak, Yashwant , Hassanzadeh, Ali , Baradaran, Behzad , Ahmadi, Majid , Saeedi, Hossein , Tahmasebi, Safa and Jarahian, Mostafa
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Acute myeloid leukemia (AML) is a serious, life-threatening, and hardly curable hematological malignancy that affects the myeloid cell progenies and challenges patients of all ages but mostly occurs in adults. Although several therapies are available including chemotherapy, allogeneic hematopoietic stem cell transplantation (alloHSCT), and receptor...
Alternative Titles
Full title
Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients
Authors, Artists and Contributors
Author / Creator
Rahman, Heshu Sulaiman
Al-Obaidi, Zaid Mahdi Jaber
Jalil, Abduladheem Turki
Abdelbasset, Walid Kamal
Suksatan, Wanich
Dorofeev, Aleksei Evgenievich
Shomali, Navid
Chartrand, Max Stanley
Pathak, Yashwant
Hassanzadeh, Ali
Baradaran, Behzad
Ahmadi, Majid
Saeedi, Hossein
Tahmasebi, Safa
Jarahian, Mostafa
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_f28583801b814fceaa78f71fb9264eaf
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f28583801b814fceaa78f71fb9264eaf
Other Identifiers
ISSN
1757-6512
E-ISSN
1757-6512
DOI
10.1186/s13287-021-02420-8
